Generic placeholder image

Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued)

Editor-in-Chief

ISSN (Print): 2212-7070
ISSN (Online): 2212-7089

Oral Corticosteroid Use in Exacerbations of Asthma

Author(s): Bronwyn S. Berthon and Lisa G. Wood

Volume 2, Issue 1, 2015

Page: [2 - 3] Pages: 2

DOI: 10.2174/2212707002666150713173515

Price: $65

Abstract

Exacerbations of asthma are treated with oral corticosteroid medications which are associated with various adverse effects that impact negatively on patient adherence. Historically oral corticosteroid use has been associated with weight gain, increased appetite and dietary intake, though new evidence suggests that these effects are not associated with short term use. Impaired response to oral corticosteroids is also an issue in some patients due to steroid resistance. A new study suggests that inflammometry can be used to guide patient selection for oral corticosteroid therapy to improve responses. While oral corticosteroids remain the mainstay of treating asthma exacerbations, clinicians should give consideration to using inflammometry for patient selection and providing guidance on the likelihood and management of adverse effects.

Keywords: Asthma, environmental exposure, inflammation, OCS therapy, oral corticosteroid, short-term OCS.


Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy